VX15/2503
VX15/2503-N-101
Phase 1 small_molecule completed
Quick answer
VX15/2503 for Multiple Sclerosis is a Phase 1 program (small_molecule) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VACCINEX, INC.
- Indication
- Multiple Sclerosis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed